Clean Science and Technology and GR Infraprojects are headed to the market with their initial share-sale offers next week to raise a little over Rs 2,500 crore cumulatively. (Image: Shutterstock)

live

bselive
nselive

Volume

Todays L/H

ICICI Direct IPO report on Clean Science and Technology

Incorporated in 2003, Clean Science and Technology manufactures critical specialty chemicals such as performance chemicals (MEHQ, BHA, AP), pharmaceutical intermediates (Guaiacol, DCC), and FMCG chemicals (4-MAP and Anisole). The company’s products are used as key starting level materials, as inhibitors, or as additives, by customers, for products sold in regulated markets. Key customers include Bayer AG, SRF Ltd, Gennex Laboratories, Nutriad International NV and Vinati Organics. It has two certified production facilities with a combined installed capacity of 29,900 MTPA in India strategically in Kurkumbh (Maharashtra), in close proximity to the JNPT port.

Valuation and Outlook

At Rs 900, the stock is available at 48.2x FY21. We assign a SUBSCRIBE rating to the issue.

For all IPO stories, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Subscribe to Clean Science and Technology: ICICI Direct

ICICI Direct has come out with its report on Clean Science and Technology. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 06, 2021.

Clean Science and Technology and GR Infraprojects are headed to the market with their initial share-sale offers next week to raise a little over Rs 2,500 crore cumulatively. (Image: Shutterstock)